Effect of portal venous injection of donor spleen cells on skin allograft survival in rat

Indian Journal of Medical Research

Volumn 119, Issue 3, 2004, Pages 110-114

  Kara, Eray ^a   Içöz, Gökhan ^b   Dayangaç, Murat ^b   Ilkgül, Özer ^a   Ertan, Hikmet ^b   Tokat, Yaman ^b   Terzioglu, Ender ^b  

^a Dept Int Med Mediterranean Univ ^*  (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Donor spleen cells; Skin allograft; Survival; Swiss albino rats

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELL TRANSFER; CELL VIABILITY; CONNECTIVE TISSUE; CONTROLLED STUDY; DONOR; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; INTERMETHOD COMPARISON; MALE; MICROSCOPY; NECROSIS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERIOPERATIVE PERIOD; PORTAL VEIN; RAT; RAT STRAIN; SKIN ALLOGRAFT; SPLEEN CELL; TISSUE REPAIR; TRANSPLANTATION TOLERANCE; VASCULARIZATION;

ANIMALS; CELL TRANSPLANTATION; GRAFT SURVIVAL; INJECTIONS, INTRAVENOUS; MALE; PORTAL VEIN; RATS; SKIN TRANSPLANTATION; SPLEEN; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 1842844332     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Sollinger HW, Burlingham WJ, Sparks EM, Glass NR, Belzer FO. Donor-specific transfusions in unrelated and related HLA-mismatched donor-recipient combinations. Transplantation 1984; 38 : 612-5.
2. Homan WP, Williams KA, Millard PR, Morris PJ. Prolongation of renal allograft survival in the rat by pretreatment with donor antigen and cyclosporin A. Transplantation 1981; 31 : 423-7.
3. Takiff H, Novak M, Yin L, Iwaki Y, Terasaki PI. Examination of the clonal deletion hypothesis following transfusions in rat cardiac transplants. Transplantation 1987; 43 : 145-51.
4. Hendry WS, Tilney NL, Baldwin WM 3rd, Graves MJ, Milford E, Strom TB, et al. Transfer of specific unresponsiveness to organ allografts by thymocytes. J Am Soc Nephrol 1999; 10 : 2454-63.
5. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172 : 603-7.
6. Martinelli GP, Horowitz C, Chiang K, Racelis D, Schanzer H. Pre-transplant conditioning with donor-specific transfusions using heated blood and cyclosporine: preservation of the transfusion effect in the absence of sensitization. Transplantation 1987; 43 : 140-5.
7. Rao VK, Burris DE, Gruel SM, Sollinger HW, Burlingham WJ. Evidence that donor spleen cells administrated through the portal vein prolong the survival of cardiac allografts in rats. Transplantation 1988; 45 : 1145-6.
8. Tsuji T, Tashiro S, Tanabe D, Sawada T, Inoue K, Kawamoto S, et al. The effect of perioperative portal venous injection of donor spleen cells on renal allograft survival in dogs. Transplantation 1994; 58 : 883-6.
9. Markees TG, Phillips NE, Noelle RJ, Shultz LD, Mordes JP, Greiner DL, et al. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 1997; 64 : 329-35.
10. Markees TG, De Fazio SR, Gozzo JJ. Prolongation of adult skin allograft survival by contransplantation of neonatal skin in anti-lymphocyte serum and donor bone marrow cell-treated mice. Transplantation 1990; 50 : 911-4.
11. Qian JH, Hashimato T, Fujiwara H, Hamaoka T. Studies on the induction of tolerance to alloantigens. The abrogation of potentials for delayed-type hypersensitivity responses to alloantigens by portal venous inoculation with allogeneic cells. J Immunol 1985; 134 : 3656-61.
12. Kenick S, Lowry RP, Forbes RDS, Lisbona R. Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: what is "hepatic tolerance". Transplant Proc 1987; 19 : 478-80.
13. Gorczynski RM. Immunosupression induced by hepatic portal venous immunization spares reactivity in IL-4 producing T lymphocytes. Immunol Lett 1992; 33 : 67-77.
14. Gorczynski RM, Wojcik D. A role for non-specific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1 and interleukin-10) immunomodulation in the prolongation of skin allografts after antigen-specific pre-transplant immunization or transfusion. J Immunol 1994; 152 : 2011-9.
15. Gorczyzski RM, Kiziroglu F. Tolerance induction to multiple minor histoincompatible cells is associated with preferential activation of Th2 cells. Transplantation 1994; 58 : 51-8.
16. Triger DR, Cynamon MH, Wright R. Studies on hepatic uptake of antigen: I. Comparison of inferior vena cava and portal vein routes of immunization. Immunology 1973; 25 : 941-50.
17. Wang YB, Ogawa Y, Doi H, Kusumoto K, Jin TN, Ikehara S. Long-term immunologic induction of donor-specific tolerance to skin allografts by bone marrow transplant in rabbits. Plast Reconstr Surg 2003; 111 : 298-9.
18. Genden EM, Mackinnon SE, Yu S, Hunter DA, Flye MW. Portal venous ultraviolet B-irradiated donor alloantigen prevents rejection in circumferential rat tracheal allografts. Otolaryngol Head Neck Surg 2001; 124 : 481-8.
19. Nagano H, Tanigawa T, Yoshida T, Ota H, Akagi K, Hasuike Y, et al. Role of micro-chimerism in inducing immunological tolerance by intraportal injection of donor spleen cells in rats. Cell Transplantation 1995; 4 : 59-60.
20. Dorsch S, Roser B. Recirculating suppressor T cells in transplantation tolerance. J Exp Med 1977; 145 : 1144-57.
21. Kilshaw PJ, Brent L. Further studies on suppressor T cells in mice unresponsiveness to H-2 incompatible skin grafts. Transplant Proc 1977; 9 : 717-9.
22. Kamei T, Callery MP, Flye MW. Kuppfer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation. J Surg Res 1990; 48 : 393-6.
23. Satoh S, Quian JH, Kokudo S, Ikegami R, Suda T, Hamaoka T, et al. Studies on the induction of tolerance to alloantigens: III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route. J Immunol 1988; 140 : 717-22.
24. Yoshimura N, Matsui S, Hamashima T, Lee CJ, Ohsaka Y, Oka T. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat: I. Specific prolongation of donor grafts and suppressor factor in the serum. Transplantation 1990; 49 : 167-71.
25. Qian JH, Hashimato T, Fujiwara H, Hamaoka T. Studies on the induction of tolerance to alloantigens: the abrogation of potentials for delayed type hypersensitivity responses to alloantigens by portal venous inoculation with allogeneic cells. J Immunol 1987; 139 : 3656-9.
26. Kenick S, Lisbona R, Marghesco D, Lowry RP. Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: immunologically specific entrapment of allogeneic cells within the liver. Transplant Proc 1987; 19 : 3057-61.
27. Kamei T, Callery MP, Flye MW. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolongs rat cardiac allograft survival. Surgery 1990; 108 : 415-21.
28. Starzl TE. The birth of clinical organ transplantation. J Am Coll Surg 2001; 192 : 431-46.
29. d-specific skin graft survival in transgenic 2CF1 mice. Transpl Immunol 2003; 11 : 23-9.